GGrantIndex
Sort

34,240 grants matching atherosclerosis

Macrophage Dysfunction in Obesity, Diabetes and Atherosclerosis

$2,409,733
Edward A Fisher · New York University School Of Medicine · P01 · FY2021 · HL

Triglycerides, Diabetes and Cardiovascular Disease

$2,409,622
Karin E. Bornfeldt · University Of Washington · P01 · FY2020 · HL

Glucose instability and neurocognitive outcomes in older adults

$2,408,159
Elizabeth Selvin · Johns Hopkins University · RF1 · FY2021 · AG

Cardiovascular Disease and Diabetes Program Project

$2,406,329
Karin E. Bornfeldt · University Of Washington · P01 · FY2019 · HL

Molecular Genetic Approaches in Atherosclerosis Research

$2,405,344
Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2013 · HL

Signal Transduction in Atherosclerosis

$2,404,006
Garret A Fitzgerald · University Of Pennsylvania · P01 · FY2009 · HL

Endothelial Redox State & Phenotype in Health & Disease

$2,403,760
Kenneth Walsh · Boston University Medical Campus · P01 · FY2009 · HL

Chemical Receptor Interactions In Reproduction And Hormonal Toxicity

$2,402,817
Kenneth S Korach · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES

DISCOVER Center: Cardiovascular Disease and Traffic-Related Air Pollution

$2,402,615
Joel Daniel Kaufman · University Of Washington · P50 · FY2012 · ES

Cardiovascular Disease and Diabetes Program Project

$2,401,515
Karin E. Bornfeldt · University Of Washington · P01 · FY2015 · HL

Cell Adhesion and Signaling in Blood and Vascular Cells

$2,400,600
Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P01 · FY2021 · HL

Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic disease (PACI) Initiative

$2,400,326
Nehal Mehta · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Molecular mechanisms and pathways of novel genomic loci regulating plasma lipids

$2,400,000
Daniel James Rader · University Of Pennsylvania · RC2 · FY2009 · HL

SCOR in Molecular Medicine and Atherosclerosis

$2,397,891
Joseph L Witztum · University Of California, San Diego · P50 · FY2006 · HL

Platelet signals and their interface with the external environment

$2,397,790
Charles S Abrams · University Of Pennsylvania · P01 · FY2015 · HL

Rare variants and NHLBI traits in deeply phenotyped cohorts

$2,394,488
Bruce M Psaty · University Of Washington · R01 · FY2015 · HL

Macrophage Dysfunction in Obesity, Diabetes and Atherosclerosis

$2,393,695
Edward A Fisher · New York University School Of Medicine · P01 · FY2019 · HL

Nutrition and Superfund Chemical Toxicity

$2,393,534
Bernhard Hennig · University Of Kentucky · P42 · FY2017 · ES

Combined Cardiopulmonary Failure in COPD: SPIROMICS HF

$2,391,491
R Graham Barr · Columbia University Health Sciences · R01 · FY2019 · HL

Vascular Cell Signaling and Atherogenesis

$2,391,218
Weill Medical College Of Cornell Univ · P01 · FY2002 · HL

Pathophysiology of the Endothelium

$2,390,704
Francis W. Luscinskas · Brigham And Women'S Hospital · P01 · FY2010 · HL

Triglycerides, Diabetes and Cardiovascular Disease

$2,390,187
Karin E. Bornfeldt · University Of Washington · P01 · FY2023 · HL

MESA

$2,389,041
Karol Watson · University Of California Los Angeles · N01 · FY2009 · HL

Protective Mechanisms In Cerebral Ischemia

$2,388,918
John Hallenbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS

HDL Function in Human Disease

$2,388,576
Macrae F Linton · Vanderbilt University Medical Center · P01 · FY2018 · HL